<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We scored <z:e sem="disease" ids="C1568868" disease_type="Disease or Syndrome" abbrv="">oral mucositis</z:e> and gut toxicity and measured sugar permeability testing among 56 recipients of a haematopoietic stem cell transplant (HSCT) given myeloablative conditioning with <z:chebi fb="0" ids="42068">idarubicin</z:chebi>, <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> and TBI, and a group of 18 patients given cytotoxic chemotherapy for newly diagnosed <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_342'>myeloid leukaemia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) or <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>Gut integrity was already disturbed in the <z:e sem="disease" ids="C1332153" disease_type="Neoplastic Process" abbrv="">AML/MDS</z:e> group as measured by the lactulose/<z:chebi fb="0" ids="26546">rhamnose</z:chebi> ratio (L/R ratio=0.09) before therapy and was severely perturbed (L/R ratio &gt;0.13) for a month after HSCT </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C1568868" disease_type="Disease or Syndrome" abbrv="">Oral mucositis</z:e> and to a lesser extent gut toxicity was only significantly correlated with disturbed permeability in the transplant group </plain></SENT>
<SENT sid="3" pm="."><plain>The data suggest that sugar permeability, <z:e sem="disease" ids="C1568868" disease_type="Disease or Syndrome" abbrv="">oral mucositis</z:e> and gut toxicity measure different features of mucosal damage after intensive cytotoxic therapy </plain></SENT>
</text></document>